Plus Therapeutics(NASDAQ:PSTV) 
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system...
Website: https://www.plustherapeutics.com
Founded: 1996
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.75
H 0.88
L 0.75
C 0.79
V 1,276,473
10EMA 0.79
20EMA 0.79
60EMA 0.79
120EMA 0.79
250EMA 0.79